Role of structural MRI in Alzheimer's disease

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Atrophy measured on structural magnetic resonance imaging (sMRI) is a powerful biomarker of the stage and intensity of the neurodegenerative aspect of Alzheimer's disease (AD) pathology. In this review, we will discuss the role of sMRI as an AD biomarker by summarizing (a) the most commonly used methods to extract information from sMRI images, (b) the different roles in which sMRI can be used as an AD biomarker, and (c) comparisons of sMRI with other major AD biomarkers.

Original languageEnglish (US)
Article number23
JournalAlzheimer's Research and Therapy
Volume2
Issue number4
DOIs
StatePublished - 2010

Fingerprint

Alzheimer Disease
Magnetic Resonance Imaging
Biomarkers
Atrophy
Pathology

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Cognitive Neuroscience

Cite this

Role of structural MRI in Alzheimer's disease. / Vemuri, Prashanthi D; Jack, Clifford R Jr.

In: Alzheimer's Research and Therapy, Vol. 2, No. 4, 23, 2010.

Research output: Contribution to journalArticle

@article{53e023a919b340e1b934220c9a89f1c8,
title = "Role of structural MRI in Alzheimer's disease",
abstract = "Atrophy measured on structural magnetic resonance imaging (sMRI) is a powerful biomarker of the stage and intensity of the neurodegenerative aspect of Alzheimer's disease (AD) pathology. In this review, we will discuss the role of sMRI as an AD biomarker by summarizing (a) the most commonly used methods to extract information from sMRI images, (b) the different roles in which sMRI can be used as an AD biomarker, and (c) comparisons of sMRI with other major AD biomarkers.",
author = "Vemuri, {Prashanthi D} and Jack, {Clifford R Jr.}",
year = "2010",
doi = "10.1186/alzrt47",
language = "English (US)",
volume = "2",
journal = "Alzheimer's Research and Therapy",
issn = "1758-9193",
publisher = "BioMed Central",
number = "4",

}

TY - JOUR

T1 - Role of structural MRI in Alzheimer's disease

AU - Vemuri, Prashanthi D

AU - Jack, Clifford R Jr.

PY - 2010

Y1 - 2010

N2 - Atrophy measured on structural magnetic resonance imaging (sMRI) is a powerful biomarker of the stage and intensity of the neurodegenerative aspect of Alzheimer's disease (AD) pathology. In this review, we will discuss the role of sMRI as an AD biomarker by summarizing (a) the most commonly used methods to extract information from sMRI images, (b) the different roles in which sMRI can be used as an AD biomarker, and (c) comparisons of sMRI with other major AD biomarkers.

AB - Atrophy measured on structural magnetic resonance imaging (sMRI) is a powerful biomarker of the stage and intensity of the neurodegenerative aspect of Alzheimer's disease (AD) pathology. In this review, we will discuss the role of sMRI as an AD biomarker by summarizing (a) the most commonly used methods to extract information from sMRI images, (b) the different roles in which sMRI can be used as an AD biomarker, and (c) comparisons of sMRI with other major AD biomarkers.

UR - http://www.scopus.com/inward/record.url?scp=77956301807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956301807&partnerID=8YFLogxK

U2 - 10.1186/alzrt47

DO - 10.1186/alzrt47

M3 - Article

C2 - 20807454

AN - SCOPUS:77956301807

VL - 2

JO - Alzheimer's Research and Therapy

JF - Alzheimer's Research and Therapy

SN - 1758-9193

IS - 4

M1 - 23

ER -